EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer

被引：0
|
作者：
Moiseyenko, V. [1 ]
Imyanitov, E. [1 ]
Levchenko, E. [1 ]
Procenko, S. [1 ]
Orlova, R. [1 ]
Iyevleva, A. [1 ]
Buslov, K. [1 ]
Ulibina, Y. [1 ]
Matsko, D. [1 ]
Moiseyenko, F. [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19075
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prevalence of EGFR Mutations in Brazilian Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
    Lima, Ellias Abreu
    Sales, Paulo Guilherme
    Vilaca, Israel
    Perillo, Fernanda
    Almeida, Flavia
    Martins, Graziella
    Goncalves, Mariana
    Toledo, Joseane
    Giovani, Poliana
    Silva, Wania
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1443 - S1444
  • [2] Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Mori, Masahide
    Ichiki, Masao
    Sukoh, Noriaki
    Kada, Akiko
    Saito, Akiko M.
    Ichinose, Yukito
    [J]. IN VIVO, 2019, 33 (02): : 477 - 482
  • [3] Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [4] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] Reflex Testing of EGFR and ALK in Non-Squamous Non-Small Cell Lung Cancer
    Tan, Jonan Z. -E.
    Ong, Whee-Sze
    Tan, Daniel S. -W.
    Takano, Angela
    Lim, Tony Kiat-Hon
    Chan, Kian-Sing
    Oon, Lynette Lin-Ean
    Lim, Alvin Soon-Tiong
    Jain, Amit
    Toh, Chee-Keong
    Ang, Mei-Kim
    Ng, Quan-Sing
    Kanesvaran, Ravindran
    Devanand, Anantham
    Lim, Chong-Hee
    Koh, Tina Puay-Theng
    Lim, Wan-Teck
    Tan, Eng Huat
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S698 - S699
  • [7] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [8] Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
    Lamy, T.
    Cabarrou, B.
    Planchard, D.
    Quantin, X.
    Schneider, S.
    Bringuier, M.
    Besse, B.
    Perol, M.
    Girard, N.
    Schott, R.
    Chouaid, C.
    Ricordel, C.
    Gervais, R.
    Debieuvre, D.
    Audigier-Valette, C.
    Carton, M.
    Filleron, T.
    Simon, G.
    Robain, M.
    Baldini, C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1243 - S1244
  • [9] Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
    Reck, Martin
    Shankar, Geetha
    Lee, Anthony
    Coleman, Shelley
    McCleland, Mark
    Papadimitrakopoulou, Vassiliki A.
    Socinski, Mark A.
    Sandler, Alan
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 125 - 136
  • [10] The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada
    Brenner, Darren R.
    O'Sullivan, Dylan E.
    Jarada, Tamer N.
    Yusuf, Amman
    Boyne, Devon J.
    Mather, Cheryl A.
    Box, Adrian
    Morris, Donald G.
    Cheung, Winson Y.
    Mirza, Imran
    [J]. LUNG CANCER, 2023, 175 : 60 - 67
12345